First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of the first mRNA flu vaccine by the FDA is relevant to the District of Columbia as it will directly impact public health initiatives and vaccine distribution efforts within the city. Local health departments will likely be involved in the rollout and communication of this new vaccine option.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.